4527

JP:CO:ROHTO

ロート製薬株式会社

  • Stock

Last Close

3,411.00

12/11 06:45

Market Cap

779.09B

Beta: -

Volume Today

541.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
144.08B
-
151.99B
5.49%
166.48B
9.53%
154.60B
7.13%
171.79B
11.12%
183.67B
6.91%
188.38B
2.56%
181.05B
3.89%
199.65B
10.27%
238.66B
19.54%
270.84B
13.48%
cost of revenue
57.92B
-
61.40B
5.99%
67.25B
9.54%
63.25B
5.94%
70.75B
11.84%
74.05B
4.67%
74.14B
0.12%
74.33B
0.26%
83.16B
11.88%
101.24B
21.75%
115.98B
14.55%
gross profit
86.16B
-
90.60B
5.15%
99.23B
9.52%
91.34B
7.94%
101.05B
10.62%
109.62B
8.49%
114.24B
4.21%
106.73B
6.58%
116.49B
9.15%
137.42B
17.97%
154.86B
12.69%
selling and marketing expenses
40.25B
-
44.66B
10.97%
47.99B
7.45%
40.87B
14.83%
44.84B
9.73%
47.68B
6.32%
47.93B
0.52%
40.52B
15.44%
38.11B
5.95%
46.47B
21.92%
general and administrative expenses
selling general and administrative expenses
40.25B
-
44.66B
10.97%
47.99B
7.45%
40.87B
14.83%
44.84B
9.73%
47.68B
6.32%
47.93B
0.52%
40.52B
15.44%
38.11B
5.95%
46.47B
21.92%
101.31B
118.02%
research and development expenses
4.55B
-
5.58B
22.83%
5.81B
4.05%
6.12B
5.37%
6.55B
7.02%
6.83B
4.24%
7.05B
3.21%
7.90B
12.10%
8.74B
10.59%
11.06B
26.60%
13.39B
21.01%
other expenses
3M
-
301M
9,933.33%
-119M
139.53%
203M
270.59%
100M
50.74%
-40M
140%
-33M
17.50%
260M
887.88%
246M
5.38%
-63M
125.61%
cost and expenses
127.25B
-
138.83B
9.10%
150.79B
8.62%
139.14B
7.72%
152.71B
9.75%
162.85B
6.65%
165.81B
1.82%
158.06B
4.68%
170.29B
7.74%
204.70B
20.21%
230.67B
12.69%
operating expenses
69.33B
-
77.43B
11.69%
83.54B
7.89%
75.89B
9.16%
81.96B
8.00%
88.81B
8.36%
91.68B
3.23%
83.73B
8.67%
87.14B
4.06%
103.46B
18.73%
114.70B
10.86%
interest expense
165M
-
231M
40%
166M
28.14%
135M
18.67%
143M
5.93%
148M
3.50%
125M
15.54%
145M
16%
248M
71.03%
247M
0.40%
196M
20.65%
ebitda
23.32B
-
20.56B
11.82%
21.95B
6.75%
22.02B
0.31%
24.90B
13.10%
25.52B
2.47%
29.26B
14.66%
31.82B
8.76%
38.16B
19.92%
43.30B
13.46%
48.85B
12.82%
operating income
16.82B
-
13.16B
21.77%
15.68B
19.18%
15.45B
1.48%
19.09B
23.53%
20.81B
9.04%
23.09B
10.92%
22.99B
0.41%
29.35B
27.66%
33.96B
15.71%
40.17B
18.28%
depreciation and amortization
5.93B
-
6.34B
7.00%
6.45B
1.69%
5.92B
8.14%
5.91B
0.15%
6.40B
8.29%
6.94B
8.32%
6.75B
2.72%
7.67B
13.71%
7.80B
1.67%
8.69B
11.36%
total other income expenses net
-2.23B
-
586M
126.30%
-1.38B
336.01%
-704M
49.10%
-2.27B
222.44%
-4.51B
98.85%
-1.15B
74.50%
1.14B
198.96%
-240M
121.07%
751M
412.92%
1.35B
79.89%
income before tax
14.60B
-
13.75B
5.81%
14.30B
4.01%
14.75B
3.14%
16.82B
14.02%
16.30B
3.09%
21.73B
33.31%
23.01B
5.87%
27.95B
21.50%
34.29B
22.67%
41.52B
21.08%
income tax expense
5.65B
-
5.12B
9.34%
5.22B
1.83%
4.74B
9.18%
7.48B
57.94%
6.48B
13.39%
6.45B
0.51%
6.24B
3.29%
6.80B
9.09%
7.86B
15.54%
10.12B
28.79%
net income
8.95B
-
8.63B
3.53%
9.10B
5.41%
10.01B
10.04%
9.29B
7.21%
9.80B
5.49%
15.41B
57.26%
16.74B
8.65%
21.13B
26.18%
26.38B
24.85%
30.94B
17.29%
weighted average shs out
231.94M
-
226.98M
2.14%
227.34M
0.16%
227.67M
0.15%
227.83M
0.07%
227.91M
0.03%
228.08M
0.07%
228.14M
0.03%
228.14M
0%
228.14M
0.00%
228.14M
0.00%
weighted average shs out dil
232.93M
-
227.94M
2.14%
228.31M
0.16%
228.64M
0.15%
228.79M
0.07%
228.79M
0.00%
228.79M
0.00%
228.80M
0.01%
228.80M
0.00%
228.80M
0.00%
228.80M
0.00%
eps
38.58
-
38.03
1.43%
40.02
5.23%
43.98
9.90%
40.77
7.30%
43
5.47%
67.56
57.12%
73.39
8.63%
92.61
26.19%
115.62
24.85%
135.61
17.29%
epsdiluted
38.41
-
37.87
1.41%
39.85
5.23%
43.79
9.89%
40.60
7.28%
42.83
5.49%
67.36
57.27%
73.18
8.64%
92.34
26.18%
115.29
24.85%
135.21
17.28%

All numbers in (except ratios and percentages)